(Q48124163)

8 February 2018

title

High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression. (English)

1 reference

8 February 2018

author

Anne Eckert

3

1 reference

8 February 2018

Edith Holsboer-Trachsler

7

object named as

Edith Holsboer-Trachsler

1 reference

8 February 2018

5

Serge Brand

1 reference

8 February 2018

1

Thorsten Mikoteit

1 reference

8 February 2018

Ulrich Hemmeter

4

object named as

Ulrich Hemmeter

1 reference

8 February 2018

Alexandra Delini-Stula

8

object named as

Alexandra Delini-Stula

1 reference

8 February 2018

author name string

Johannes Beck

2

1 reference

8 February 2018

Roland Bischof

6

1 reference

8 February 2018

publication date

23 February 2014

1 reference

8 February 2018

published in

Psychopharmacology

1 reference

8 February 2018

volume

231

1 reference

8 February 2018

issue

15

1 reference

8 February 2018

page(s)

2955-2965

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-014-3475-8

exact match

0 references

cites work

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder

1 reference

12 December 2020

A neurotrophic model for stress-related mood disorders

1 reference

12 December 2020

Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus

1 reference

12 December 2020

Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.

1 reference

12 December 2020

Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses

1 reference

12 December 2020

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

1 reference

12 December 2020

Molecular and neural bases underlying roles of BDNF in the control of body weight

1 reference

12 December 2020

Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients.

1 reference

12 December 2020

Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants

1 reference

12 December 2020

Serum and plasma BDNF levels in major depression: a replication study and meta-analyses.

1 reference

12 December 2020

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

1 reference

12 December 2020

Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine

1 reference

12 December 2020

The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.

1 reference

12 December 2020

Relationship of serum brain-derived neurotrophic factor (BDNF) and health-related lifestyle in healthy human subjects.

1 reference

12 December 2020

Transport of brain-derived neurotrophic factor across the blood-brain barrier.

1 reference

12 December 2020

Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment

1 reference

12 December 2020

Low plasma BDNF is associated with suicidal behavior in major depression.

1 reference

12 December 2020

Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment

1 reference

12 December 2020

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

1 reference

12 December 2020

Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity

1 reference

12 December 2020

Determinants of serum brain-derived neurotrophic factor

1 reference

12 December 2020

Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation.

1 reference

12 December 2020

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.

1 reference

12 December 2020

BDNF: an indicator of insomnia?

1 reference

12 December 2020

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.

1 reference

12 December 2020

Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only.

1 reference

12 December 2020

Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment

1 reference

12 December 2020

Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment

1 reference

12 December 2020

Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects

1 reference

12 December 2020

Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

1 reference

12 December 2020

Time course of improvement under antidepressant treatment: a survival-analytical approach

1 reference

12 December 2020

Delayed onset of action of antidepressant drugs? Survey of recent results

1 reference

12 December 2020

Kinetics of serum brain-derived neurotrophic factor following low-intensity versus high-intensity exercise in men and women.

1 reference

12 December 2020

Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode

1 reference

12 December 2020

The impact of age, weight and gender on BDNF levels in human platelets and plasma

1 reference

12 December 2020

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

1 reference

12 December 2020

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

1 reference

12 December 2020

Serum neurotrophins--a study on the time course and influencing factors in a large old age sample.

1 reference

12 December 2020

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

1 reference

12 December 2020

Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.

1 reference

12 December 2020

Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants

1 reference

12 December 2020

The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels

1 reference

12 December 2020

Evolution of the vertebrate neurotrophin and Trk receptor gene families

1 reference

12 December 2020

Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats.

1 reference

12 December 2020

Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.

1 reference

12 December 2020

Steroid hormones and BDNF.

1 reference

12 December 2020

10.1007/S00213-014-3475-8

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018